{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:41:25Z","timestamp":1791312085091,"version":"4.3.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.tranon.2025.102582","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:30:03Z","timestamp":1761755403000},"page":"102582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Multimodal urinary biomarker panel achieves superior prostate cancer detection accuracy and reduces unnecessary biopsies"],"prefix":"10.1016","volume":"63","author":[{"given":"Yasin","family":"Panahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigir Biray","family":"Avci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ghafarlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-1335","authenticated-orcid":false,"given":"Alireza","family":"Nourazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.tranon.2025.102582_bib0002","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41391-023-00782-z","article-title":"Avoiding unnecessary biopsy: the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decision","volume":"27","author":"Guo","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0003","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41391-023-00765-0","article-title":"Concerns regarding prostate cancer screening guidelines in minority populations","volume":"27","author":"Sweis","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0004","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/JU.0000000000003603","article-title":"Free PSA and clinically significant and fatal prostate cancer in the PLCO screening trial","volume":"210","author":"Yim","year":"2023","journal-title":"J. Urol."},{"key":"10.1016\/j.tranon.2025.102582_bib0005","doi-asserted-by":"crossref","unstructured":"Yao W., Wu J., Kong Y., et al. Associations of systemic immune-inflammation index with high risk for prostate cancer in middle-aged and older US males: a population-based study. Immun Inflamm Dis. Jun 2024;12(6):e1327. doi:10.1002\/iid3.1327.","DOI":"10.1002\/iid3.1327"},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0006","first-page":"354","article-title":"Exploration and validation of optimal cut-off values for tPSA and fPSA\/tPSA screening of prostate cancer at different ages]","volume":"46","author":"Liu","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"15","key":"10.1016\/j.tranon.2025.102582_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153973","article-title":"Abrogating metastatic properties of triple-negative breast cancer cells by EGFR and PI3K dual inhibitors","volume":"15","author":"Garcia","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0008","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40364-024-00626-5","article-title":"Dysregulation of plasma circulating microRNAs in all-cause and cause-specific cancers: the Rotterdam Study","volume":"12","author":"Shuai","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.tranon.2025.102582_bib0009","article-title":"Prostate cancer and microRNAs: new insights into apoptosis","volume":"245","author":"Gupta","year":"2023","journal-title":"Pathol. Res. Pr."},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12967-023-03941-x","article-title":"Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas","volume":"21","author":"de Godoy","year":"2023","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.tranon.2025.102582_bib0011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s13206-023-00108-0","article-title":"The detection of urinary exosomal miRNAs for cancer diagnostics and prognostics","volume":"17","author":"Kim","year":"2023","journal-title":"Biochip. J."},{"key":"10.1016\/j.tranon.2025.102582_bib0012","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1158\/1538-7445.AM2024-5042","article-title":"Abstract 5042: urine as a non-invasive proxy for plasma in prostate cancer-related liquid biopsy applications","volume":"84","author":"Jafari","year":"2024","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0013","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euo.2023.12.005","article-title":"Comparing the performance of digital rectal examination and prostate-specific antigen as a screening test for prostate cancer: a systematic review and meta-analysis","volume":"7","author":"Matsukawa","year":"2024","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.tranon.2025.102582_bib0014","article-title":"Differential expression of circulating miR-221-3p, miR-146a-5p, miR-206 and their diagnostic value in lung cancer","author":"Wani","year":"2024","journal-title":"Indian J. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ncrna.2023.08.001","article-title":"A novel microRNA panel exhibited significant potential in evaluating the progression of laryngeal squamous cell carcinoma","volume":"8","author":"Zhang","year":"2023","journal-title":"Noncoding RNA Res. Dec."},{"issue":"10","key":"10.1016\/j.tranon.2025.102582_bib0016","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/mrd.23636","article-title":"The expression level of mir-21-3p in platelet-rich plasma: a potential effective factor and predictive biomarker in recurrent implantation failure","volume":"89","author":"Babian","year":"2022","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.tranon.2025.102582_bib0017","article-title":"Circ_0057558 accelerates the development of prostate cancer through miR-1238-3p\/SEPT2 axis","volume":"243","author":"Yin","year":"2023","journal-title":"Pathol. Res. Pr. Mar"},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0018","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00345-024-05241-5","article-title":"Associations between inflammatory burden index, prostate cancer, and mortality among middle-aged and elderly individuals","volume":"42","author":"Deng","year":"2024","journal-title":"World J. Urol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0019","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/ijc.ijc_211_24","article-title":"Relationship between neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in peripheral blood and prognosis after castration therapy for prostate cancer","volume":"61","author":"Wu","year":"2024","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.tranon.2025.102582_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmoldx.2025.02.006","article-title":"Platelets, chromogranin A, and C-reactive protein predict therapy failure of metastatic hormone-sensitive prostate cancer while miR-375 outperforms prostate-specific antigen in stratifying castration-resistant prostate cancer","author":"Chrenkova","year":"2025","journal-title":"J. Mol. Diagn. Mar"},{"issue":"6","key":"10.1016\/j.tranon.2025.102582_bib0021","article-title":"The relationship of the neutrofil lymphocyte ratio (Rnl) with the gleason score of prostate cancer patients","volume":"13","author":"Aristo","year":"2024","journal-title":"E-J. Medika Udayana"},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0022","article-title":"Association between the neutrophil-to-lymphocyte ratio and cancer in adults from NHANES 2005-2018: a cross-sectional study","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0023","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/siuj5040044","article-title":"The neutrophil-to-lymphocyte ratio as a biomarker in metastatic castrate-sensitive prostate cancer patients treated with abiraterone acetate","volume":"5","author":"Suartz","year":"2024","journal-title":"Soc. Int. Urol. J."},{"issue":"11","key":"10.1016\/j.tranon.2025.102582_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16111347","article-title":"MicroRNAs as promising therapeutic agents against prostate cancer resistant to castration-where are we now?","volume":"16","author":"Ferreira","year":"2024","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.tranon.2025.102582_bib0025","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.tjnut.2023.05.015","article-title":"Orchestration of miRNA patterns by testosterone and dietary tomato carotenoids during early prostate carcinogenesis in TRAMP mice","volume":"153","author":"Wan","year":"2023","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/j.tranon.2025.102582_bib0026","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.acuro.2023.09.005","article-title":"Clinical evaluation and treatment in men with low testosterone levels and prostate cancer","volume":"48","author":"Ljubetic","year":"2024","journal-title":"Actas. Urol. Esp. (Engl. Ed.)"},{"issue":"7","key":"10.1016\/j.tranon.2025.102582_bib0027","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.4103\/jfmpc.jfmpc_2349_21","article-title":"Relationship between endogenous testosterone and prostate carcinoma","volume":"11","author":"Paunikar","year":"2022","journal-title":"J. Fam. Med. Prim. Care"},{"issue":"12","key":"10.1016\/j.tranon.2025.102582_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123140","article-title":"Deregulated microRNAs involved in prostate cancer aggressiveness and treatment resistance mechanisms","volume":"15","author":"Gujrati","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.tranon.2025.102582_bib0029","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4111\/icu.20210493","article-title":"Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone","volume":"63","author":"Kang","year":"2022","journal-title":"Investig. Clin. Urol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102582_bib0030","article-title":"Predictors of In-hospital death in patients with acute myocardial infarction","volume":"15","author":"Sasaki","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.tranon.2025.102582_bib0031","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/0122115366305985240502094814","article-title":"Urinary miRNAs: technical updates","volume":"13","author":"Raveendran","year":"2024","journal-title":"Microrna"},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0032","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3233\/CBM-201600","article-title":"The discriminative ability of Prostate Health Index to detect prostate cancer is enhanced in combination with miR-222-3p","volume":"30","author":"Tolle","year":"2021","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.tranon.2025.102582_bib0033","doi-asserted-by":"crossref","DOI":"10.1177\/1756287221997186","article-title":"Prostate cancer biomarkers and multiparametric MRI: is there a role for both in prostate cancer management?","volume":"13","author":"Saltman","year":"2021","journal-title":"Ther. Adv. Urol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102582_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081064","article-title":"Accuracy of tumour-associated circulating endothelial cells as a screening biomarker for clinically significant prostate cancer","volume":"11","author":"Bhakdi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2025.102582_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3995789","article-title":"The role of PSA density among PI-RADS v2.1 categories to avoid an unnecessary transition zone biopsy in patients with PSA 4-20 ng\/mL","volume":"2021","author":"Wang","year":"2021","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0036","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41420-023-01696-4","article-title":"Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells","volume":"8","author":"Canovai","year":"2023","journal-title":"Cell Death Discov. Dec"},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0037","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12672-025-01883-y","article-title":"MiRNA-21 promotes the migration and proliferation of prostate cancer cells via activating the JAK\/STAT pathway","volume":"16","author":"Han","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0038","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12957-025-03732-2","article-title":"An update on the molecular mechanisms underlying the progression of miR-21 in oral cancer","volume":"23","author":"Prasad","year":"2025","journal-title":"World J. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2025.102582_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/genes12121900","article-title":"Epithelial-mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics","volume":"12","author":"Chaves","year":"2021","journal-title":"Genes"},{"issue":"8","key":"10.1016\/j.tranon.2025.102582_bib0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.20892\/j.issn.2095-3941.2025.0149","article-title":"The immune landscape of systemic inflammation in prostate cancer","volume":"22","author":"Zhang","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"8","key":"10.1016\/j.tranon.2025.102582_bib0041","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s12276-022-00837-6","article-title":"MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4\/STAT3 axis","volume":"54","author":"Gan","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"21","key":"10.1016\/j.tranon.2025.102582_bib0042","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/s41388-024-03021-4","article-title":"The lincRNA JUNI regulates the stress-dependent induction of c-Jun, cellular migration and survival through the modulation of the DUSP14-JNK axis","volume":"43","author":"Kumar","year":"2024","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.tranon.2025.102582_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34950","article-title":"A systematic review of mechanisms of PTEN gene down-regulation mediated by miRNA in prostate cancer","volume":"10","author":"Bergez-Hernandez","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0044","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-95206-4","article-title":"The interaction between DeltaNp63alpha and TAp63alpha, mediated by miR-205-5p, inhibits the migration of lung adenocarcinoma cells","volume":"15","author":"Qobadi-Nasr","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0045","doi-asserted-by":"crossref","DOI":"10.3892\/or.2025.8879","article-title":"Bone metastases of prostate cancer: molecular mechanisms, targeted diagnosis and targeted therapy (Review)","volume":"53","author":"Guo","year":"2025","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0046","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pros.23714","article-title":"miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer","volume":"79","author":"Ghorbanmehr","year":"2019","journal-title":"Prostate"},{"issue":"03","key":"10.1016\/j.tranon.2025.102582_bib0047","doi-asserted-by":"crossref","DOI":"10.55677\/IJCSMR\/V4I3-01\/2024","article-title":"Diagnosis and prognosis utility of microrna-205 expression in prostate carcinogenesis: meta-analysis and bioinformatics study","volume":"04","author":"Gazzaz","year":"2024","journal-title":"Int. J. Clin. Sci. Med. Res."},{"key":"10.1016\/j.tranon.2025.102582_bib0048","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/146170","article-title":"MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samples","author":"Cannistraci","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0049","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/1354750X.2023.2166587","article-title":"Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population","volume":"28","author":"Zhang","year":"2023","journal-title":"Biomarkers"},{"issue":"3","key":"10.1016\/j.tranon.2025.102582_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031980","article-title":"The role of different types of microRNA in the pathogenesis of breast and prostate cancer","volume":"24","author":"Sidorova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.tranon.2025.102582_bib0051","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ncrna.2024.04.004","article-title":"Integrated grade-wise profiling analysis reveals potential plasma miR-373-3p as prognostic indicator in Prostate Cancer & its target KPNA2","volume":"9","author":"Khan","year":"2024","journal-title":"Noncoding RNA Res. Sep"},{"key":"10.1016\/j.tranon.2025.102582_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1394292","article-title":"Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers","volume":"14","author":"Chrenkova","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2025.102582_bib0053","first-page":"179","article-title":"Expression of miRNAs in prostate cancer cell lines and prostate epithelial cell lines","author":"e","year":"2023","journal-title":"Int. J. Med. Biochem."},{"issue":"16","key":"10.1016\/j.tranon.2025.102582_bib0054","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70106","article-title":"The miRNAs 203a\/210-3p\/5001-5p regulate the androgen\/androgen receptor\/YAP-induced migration in prostate cancer cells","volume":"13","author":"Huo","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2025.102582_bib0055","article-title":"Urinary MicroRNAs as biomarkers of urological cancers: a systematic review","volume":"29","author":"Aveta","year":"2023","journal-title":"Int. J. Mol. Sci. Jun"},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0056","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12894-021-00902-8","article-title":"Isolation and characterization of urine microvesicles from prostate cancer patients: different approaches, different visions","volume":"21","author":"Garcia-Flores","year":"2021","journal-title":"BMC Urol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0057","article-title":"Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis","volume":"15","author":"Singh","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tranon.2025.102582_bib0058","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1186\/s12967-025-06941-1","article-title":"Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma","volume":"23","author":"De Gregorio","year":"2025","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.tranon.2025.102582_bib0059","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70087","article-title":"Defining biological variability, analytical precision and quantitative biophysiochemical characterization of Human urinary extracellular vesicles","volume":"14","author":"Aksamitiene","year":"2025","journal-title":"J. Extracell Vesicles"},{"issue":"4","key":"10.1016\/j.tranon.2025.102582_bib0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/clinchem\/hvab002","article-title":"Serum prostate-specific antigen testing for early detection of prostate cancer: managing the gap between clinical and laboratory practice","volume":"67","author":"Ferraro","year":"2021","journal-title":"Clin. Chem."},{"issue":"28","key":"10.1016\/j.tranon.2025.102582_bib0061","article-title":"Clinical translation of extracellular vesicles","volume":"12","author":"Ghodasara","year":"2023","journal-title":"Adv. Heal. Mater."},{"key":"10.1016\/j.tranon.2025.102582_bib0062","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241290029","article-title":"Advancements in biomarkers of prostate cancer: a review","volume":"23","author":"Agbetuyi-Tayo","year":"2024","journal-title":"Technol. Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.tranon.2025.102582_bib0063","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s40273-024-01466-9","article-title":"Prognostic testing for prostate cancer-A cost-effectiveness analysis comparing a prostatype P-score biomarker approach to standard clinical practice","volume":"43","author":"Fridhammar","year":"2025","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.tranon.2025.102582_bib0064","article-title":"Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysis","volume":"16","author":"Op 't Hoog","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102582_bib0065","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MOU.0000000000001308","article-title":"Blood- and urine-based biomarkers for the detection of clinically significant prostate cancer: a contemporary review","volume":"35","author":"Assani","year":"2025","journal-title":"Curr. Opin. Urol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102582_bib0066","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jamaoncol.2024.0455","article-title":"Development and validation of an 18-gene urine test for high-grade prostate cancer","volume":"10","author":"Tosoian","year":"2024","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102582_bib0067","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41391-023-00675-1","article-title":"ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis","volume":"26","author":"Tutrone","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:01:10Z","timestamp":1773820870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325003134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":67,"alternative-id":["S1936523325003134"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102582","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal urinary biomarker panel achieves superior prostate cancer detection accuracy and reduces unnecessary biopsies","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. CCBYLICENSE","name":"copyright","label":"Copyright"}],"article-number":"102582"}}